Nanomedicine News

RSS
FDA Approval Received for Starting TKM-PLK1 Phase 1 Clinical Trial

FDA Approval Received for Starting TKM-PLK1 Phase 1 Clinical Trial

ETH Professor Receives 2010 Debiopharm Life Sciences Award

Researchers Discover New Class of Edible Nanostructures

Celator Pharmaceuticals Announces Investment to Advance CPX-351 Liposome Injection

Nanodermatology Society Calls for Multidisicplinary Approach to Provide Education and Oversight in Nanotechnology and Dermatology

Nanodermatology Society Calls for Multidisicplinary Approach to Provide Education and Oversight in Nanotechnology and Dermatology

Gold Nanoparticles Power Quick and Colorful Method to Detect Protein–DNA Interactions with Nucleotide-Specific Sensitivity

Nanosize Biological Particles with Potential To Fight Cancer and Other Illnesses

Geospiza And SAIC-Frederick Announces Collaboration On Cancer Research

IntelGenx Partners with RedHill Biopharma to Commercialize First Oral Thin Film Product

IntelGenx Partners with RedHill Biopharma to Commercialize First Oral Thin Film Product

New Sterling’s Derma Mist Fights Skin Disorders Using Nano Silver Particles

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.